Currently, research on biomarkers for ICIs efficacy mainly focuses on several aspects, including PD-L1 expression levels, tumor-infiltrating lymphocytes, TLS, Tumor genomic alterations, Transcriptome Signatures, circulating biomarkers, and microbiomes. Here, CD274 is linked to neoplasm.